Skip to main content
Funded Studies

Jay S. Schneider, PhD

Professor of Pathology, Anatomy and Cell Biology, and Neurology at Thomas Jefferson University

Location: Philadelphia, PA United States

Jay S. Schneider, PhD, received his PhD from the State University of New York at Stony Brook and received postdoctoral training at the University of California, Los Angeles. Dr. Schneider leads basic and clinical research efforts on Parkinson’s disease at Thomas Jefferson University. His research focuses on the following areas: (i) understanding the pathophysiology of Parkinson’s disease and developing neuroprotective/neurorestorative therapies for the disease, (ii) development and evaluation of new treatments to alleviate motor symptoms of Parkinson’s disease, (iii) development of anti-dyskinesia therapies, (iv) understanding cognitive dysfunction in Parkinson’s disease and development of new treatments for cognitive dysfunction, and (v) exploration of an epigenetic basis for development of Parkinson’s disease. Dr. Schneider also oversees a number of clinical trials of new therapeutics for Parkinson’s disease.

Associated Grants

  • Inhibition of Striatal-enriched Phosphate (STEP) to Improve Parkinson-related Cognitive Dysfunction


  • Inhibition of Striatal-Enriched Phosphatase (STEP) to Improve Parkinson-Related Cognitive Dysfunction


  • Enzymatic Degradation of Brain Complex Gangliosides to Increase Endogenous GM1 Levels: Potential Neuroprotective/Neurorestorative Therapy for Parkinson’s disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.